A nasal vaccine elicits protective CD8(+) T cell immunity against antigen shifted SARS-CoV-2 virus. . Nat Immunol 2024 Feb 20. doi: 10.1038/s41590-024-01744.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. A nasal vaccine elicits protective CD8(+) T cell immunity against antigen shifted SARS-CoV-2 virus. Nat Immunol 2024 Feb 20. doi: 10.1038/s41590-024-01744.
PMID: 38379003